Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Alcon Inc (ALC)

Alcon Inc (ALC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alcon (ALC) Clareon Suite to Get a Boost With Product Launch

With the latest launch of Clareon Toric, Alcon's (ALC) Clareon Collection of IOLs is complete in the United States.

ALC : 61.52 (-0.89%)
COO : 277.46 (-0.75%)
EYE : 34.62 (-1.59%)
EYPT : 6.50 (-9.72%)
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today new product launches in the U.S. as well as activities taking place at the upcoming American...

ALC : 61.52 (-0.89%)
AERIE PHARMACEUTICALS - INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

ALC : 61.52 (-0.89%)
AERI : 15.12 (-0.53%)
Alcon (ALC) Faces Cost Pressure, Supply Chain Disruption

Given the supply chain challenges, unfavorable foreign exchange impact and inflationary pressure, Alcon (ALC) reduces its core EPS and net sales expectations for 2022.

MCK : 354.37 (-0.28%)
ALC : 61.52 (-0.89%)
AMN : 111.55 (-3.24%)
SWAV : 285.20 (-0.58%)
Aerie (AERI) Rallies 205.6% in the Past Three Months: Here's Why

Aerie (AERI) shares have skyrocketed in the past three months after the company announced its definitive agreement with Alcon, wherein the latter will acquire the former for $770 million.

PFE : 44.12 (-0.76%)
AMGN : 233.82 (+0.34%)
ALC : 61.52 (-0.89%)
AERI : 15.12 (-0.53%)
Is This Eye Care Stock a Buy as It Strikes $770M Buyout?

Swiss eye care company Alcon (ALC) recently announced that it would acquire Aerie Pharmaceuticals (AERI) for $770 million. The deal is expected to help bolster ALC’s expansion into the ophthalmic pharmaceutical...

ABT : 103.38 (+0.29%)
ALC : 61.52 (-0.89%)
FONR : 15.21 (-0.85%)
INFU : 7.21 (+1.26%)
Why Aerie Pharmaceuticals Was Soaring So High This Week

You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you.

AERI : 15.12 (-0.53%)
ALC : 61.52 (-0.89%)
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Aerie Pharmaceuticals, Inc. (NasdaqGM: AERI)...

AERI : 15.12 (-0.53%)
ALC : 61.52 (-0.89%)
SHAREHOLDER ALERT: Weiss Law Investigates Aerie Pharmaceuticals, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerie Pharmaceuticals,...

AERI : 15.12 (-0.53%)
ALC : 61.52 (-0.89%)
Aerie (AERI) to be Acquired by Alcon for $770M, Shares Up

Aerie (AERI) enters into an agreement with Alcon to be acquired for $770 million. Shares gain.

NVS : 77.37 (-1.10%)
DVAX : 11.40 (+1.24%)
ALC : 61.52 (-0.89%)
AERI : 15.12 (-0.53%)

Barchart Exclusives

Hasbro’s Blueprint 2.0 Aims High. Will It Hit the Target?
Hasbro held its 2022 Investor Day on October 4. The company unveiled its blueprint for growth over the next five years. It might be biting off more than it can chew. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar